Bachem Holding (Suzhou): difference between revisions
Diff·revision 8 → 9·07:06, 11 Dec 2024
Difference between revision 8 and revision 9 of Bachem Holding (Suzhou). 5 lines changed; the page grew by 625 bytes.
| Revision 8 — 10:47, 26 Nov 2024 DiagramDelphine (talk) add the note that self-published material is usable only for what it states about itself 4,859 bytes +222 | Revision 9 — 07:06, 11 Dec 2024 AnalyticalAnnie (talk) add the minimum order quantity for custom synthesis 5,484 bytes +625 | ||
|---|---|---|---|
| 1 | {{Infobox organisation | 1 | {{Infobox organisation |
| 2 | | name = Bachem Holding (Suzhou) Co., Ltd. | 2 | | name = Bachem Holding (Suzhou) Co., Ltd. |
| + | 3 | | image = facility.svg | |
| + | 4 | | caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| 3 | | Legal name = Bachem Holding (Suzhou) Co., Ltd. | 5 | | Legal name = Bachem Holding (Suzhou) Co., Ltd. |
| 4 | | Trading name = BCH | 6 | | Trading name = BCH |
| ⋮ | ⋮ | ||
| 28 | Purchaser reports describe lyophilised material in crimped vials with a batch certificate reporting purity, appearance and, in most cases, water.{{r|reports}} Packaging has been consistently described as insulated for the temperature-sensitive lines. | 30 | Purchaser reports describe lyophilised material in crimped vials with a batch certificate reporting purity, appearance and, in most cases, water.{{r|reports}} Packaging has been consistently described as insulated for the temperature-sensitive lines. |
| 29 | 31 | ||
| + | 32 | The organisation's own material makes claims about quality systems that this wiki has not corroborated. A GMP claim in particular is not a fact until assessed against the applicable framework, and no assessment is available here.{{r|gmp,selfpub}} | |
| + | 33 | ||
| 30 | == References == | 34 | == References == |
| 31 | {{reflist}} | 35 | {{reflist}} |
| ⋮ | ⋮ | ||
| 35 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 39 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| 36 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 40 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| + | 41 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | |
| 37 | 42 | ||
| 38 | {{DEFAULTSORT:Bachem Holding (Suzhou)}} | 43 | {{DEFAULTSORT:Bachem Holding (Suzhou)}} |